T1	Participants 125 184	'high risk' pre- and postmenopausal breast cancer patients.
T2	Participants 274 321	node positive breast cancer patients in Sweden.
T3	Participants 408 447	the Stockholm Breast Cancer Study Group
T4	Participants 625 749	pre- (n = 547) and postmenopausal (n = 679) patients, respectively, with node positive disease or a tumour diameter > 30 mm.
